Cavallieri, Francesco
Bove, Francesco
Zampogna, Alessandro
Castrioto, Anna
Meoni, Sara
Gessani, Annalisa
Schmitt, Emmanuelle
Pélissier, Pierre
Valzania, Franco
Suppa, Antonio
Pinto, Serge
Chabardès, Stephan
Fraix, Valerie
Moro, Elena https://orcid.org/0000-0002-7968-5908
Article History
Received: 10 December 2024
Accepted: 2 August 2025
First Online: 25 August 2025
Declarations
:
: The work described here has been carried out in accordance with the Declaration of Helsinki. The institutional research centre authority of the Grenoble Alpes University Hospital approved the study protocol that was registered with clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT03528460) on May 17, 2018.
: Several authors received funds from Boston Scientific (BS), Medtronic (MT) manufacturers of DBS equipment, for work not related to this study. These include VF receiving honoraria for lecturing (BS, MT); SC receiving grants and personal fees (BS, MT); AC receiving grants from MT and reimbursement of travel expenses (BS, MT); EM receiving honoraria from MT and funds from AbelsonTaylor, Ipsen and French Association for Parkinson’s Disease. FC, FB, AZ, SM, AG, ES, PP, FV, AS, SP, have nothing to report.
: After a reasonable request, access to the data of this study might be granted by the authors.